Toronto Stocks Flat; Hut 8 Shares Up as CCO Resigns to Become CEO of Celsius Bitcoin
By Adriano Marchese
Canadian stocks were flat in midday trading Friday. Sector performance was mixed, with the S&P/TSX Composite Index on track to gain about 0.85% in the week. In the session, the main gains were in consumer discretionary, tech services and consumer durables, offset by losses principally in energy, health tech a investment trusts.
At midday, Canada's S&P/TSX Composite Index edged down 0.01% to 21099.73, and the blue-chip S&P/TSX 60 was flat at 1271.66.
Shares in Hut 8 rose 11% to 11.10 Canadian dollars ($8.28) after the company said Matt Prusak will resign from his role as chief commercial officer to take on the chief executive position at a new bitcoin-mining company, Celsius Bitcoin.
Other market movers:
Shares of Questerre Energy climbed by nearly 52% to C$0.25 after the company said a court agreed to stay certain provisions of a Quebec law banning oil and gas development while judicial proceedings are continuing.
Write to Adriano Marchese at adriano.marchese@wsj.com
(END) Dow Jones Newswires
January 26, 2024 12:17 ET (17:17 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks